News Archive

September 2021
Pureos Bioventures

Pureos Bioventures expands the team by the appointment of venture partners
September 2021
ImCheck Therapeutics

ImCheck Presents Preliminary Patient Response Data from the Phase I/IIa EVICTION Trial with ICT01 at ESMO Congress 2021
September 2021
Araris Biotech

Araris Biotech shortlisted in top 5 of World ADC Awards 2021 in category “Best ADC Platform Technology“
September 2021
Hummingbird Bioscience

Hummingbird Bioscience Announces US FDA Clearance of IND for First-in-Human Phase 1 Trial of HMBD-002 in Patients with Advanced Solid Tumors
September 2021
ImCheck Therapeutics

ImCheck to Present Early Patient Response Data from the EVICTION Trial at the ESMO Congress 2021
September 2021
Araris Biotech

Araris Biotech ranks TOP11 at Swiss startup Award 2021
September 2021
AM-Pharma

AM-Pharma and Kyowa Kirin sign exclusive License agreement for commercialization of Ilofotase Alfa in Japan
August 2021
Eyevensys

Eyevensys Raises $12M in a Series B Plus Funding Round
July 2021
ImCheck Therapeutics

ImCheck Publishes Seminal Paper in Cell Reports Elucidating How Butyrophilins Activate Vγ9Vδ2 T cell Function Against Tumor Cells
July 2021
AM-Pharma

AM-Pharma Appoints Mark Altmeyer as Chairman of its Supervisory Board
July 2021
AM-Pharma

AM-Pharma Enrolls First Patient in Japan for Ongoing Phase III SA-AKI Pivotal REVIVAL Trial
June 2021
Corlieve Therapeutics

uniQure to Acquire Corlieve Therapeutics and Advance its Gene Therapy Program to Treat Temporal Lobe Epilepsy (TLE)
May 2021
Hummingbird Bioscience

Hummingbird Bioscience Raises US$125 Million in Series C Financing
April 2021
ImCheck Therapeutics

ImCheck Announces Initiation of U.S. Enrollment in Phase I/IIa EVICTION Trial for ICT01
April 2021
Pureos Bioventures

Pureos Bioventures expands fund size to USD 205 million
More News News Archive